Prosecution Insights
Last updated: November 12, 2026
Application No. 18/893,618

Implant With Arched Bone Contacting Elements

Non-Final OA §102§112§DOUBLEPATENT
Filed
Sep 23, 2024
Priority
Apr 29, 2015 — provisional 62/154,599 +5 more
Examiner
SUMMITT, LYNNSY M
Art Unit
3773
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Institute For Musculoskeletal Science And Education Ltd.
OA Round
1 (Non-Final)
68%
Grant Probability
Favorable
1-2
OA Rounds
99%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
477 granted / 697 resolved
-1.6% vs TC avg
Strong +43% interview lift
Without
With
+43.4%
Interview Lift
resolved cases with interview
Typical timeline
Avg Prosecution
15 currently pending
Career history
716
Total Applications
across all art units

Office Action

§102 §112 §DOUBLEPATENT
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Priority Applicant’s claim for the benefit of a prior-filed application under 35 U.S.C. 119(e) or under 35 U.S.C. 120, 121, 365(c), or 386(c) is acknowledged. Applicant has not complied with one or more conditions for receiving the benefit of an earlier filing date under 35 U.S.C. 119(e) and 120 as follows: The later-filed application must be an application for a patent for an invention which is also disclosed in the prior application (the parent or original nonprovisional application or provisional application). The disclosure of the invention in the parent application and in the later-filed application must be sufficient to comply with the requirements of 35 U.S.C. 112(a) or the first paragraph of pre-AIA 35 U.S.C. 112, except for the best mode requirement. See Transco Products, Inc. v. Performance Contracting, Inc., 38 F.3d 551, 32 USPQ2d 1077 (Fed. Cir. 1994). The disclosures of the prior-filed applications, Application No.’s 15141655, 62301546, 62217542, and 62154599 each fail to provide adequate support or enablement in the manner provided by 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph for one or more claims of this application. None of the prior filed applications listed above provides support for at least the flared leg of the arched bone contacting element of claims 1 and 10 and those claims dependent thereon, nor for the first and second arched bone contacting elements extending from an intermediate portion of a first support beam to an intermediate portion of a second support beam, and extending parallel to one another, as required by claim 14. Accordingly, claims 1-20 receive an effective filing date of 10/25/2016, which is the filing date of application No. 15334053. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-13 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding claim 1, lines 13-14, the limitation “wherein the at least one flared leg includes a first portion attached to the body…” is unclear because line 10 recites that the flared leg is attached to the peripheral structure. It appears as though the limitation in lines 13-14 should recite that the at least one flared leg includes a first portion attached to the peripheral structure. Regarding claim 5, the limitation “wherein the at least one flared leg of the second arched bone includes a first portion attached to the body…” is unclear because claim 4 recites that the flared leg is attached to the peripheral structure. It appears as though the limitation in claim 5 should recite that the at least one flared leg of the second arched bone contacting element includes a first portion attached to the peripheral structure. Regarding claim 10, line 15 recites “wherein the flared leg includes a first, wide portion attached to the body..”. However, lines 5-6 recite that the ends of the first arched bone contacting element are attached to and integrally formed with the peripheral structure. It appears as though line 15 should recite that the flared leg includes a first, wide portion attached to the peripheral structure. Claim 10 recites the limitation "the posterior-anterior axis" in lines 3-4. There is insufficient antecedent basis for this limitation in the claim. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 10-13 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Mayer (Pat. No. US 9,364,339 B2) Regarding claims 10-13, Mayer discloses an implant 10, comprising: a body including a peripheral structure bounding an interior region (illustrated in figure 14), and a first support beam 20 extending through the interior region substantially parallel to the posterior-anterior axis (figure 14); and a first arched bone contacting element 54 having two ends, wherein both ends are attached to and integrally formed with the peripheral structure of the body of the implant (figure 14); the peripheral structure having a superior surface configured to face an endplate of a vertebral body when the implant is implanted into an intervertebral space (figure 14); wherein the first arched bone contacting element 54 extends in a superior direction from the superior surface of the peripheral structure; wherein at least one of the two ends of the first arched bone contacting element forms a flared leg (illustrated in figure 14); wherein the flared leg includes a first, wide portion attached to the body and a second, narrow portion proximate an arched portion of the first arched bone contacting element (figure 14); further including a second arched bone contacting element 54 having two ends, wherein both ends are attached to and integrally formed with the peripheral structure of the body of the implant (figure 14). The first arched bone contacting element 54 and the second arched bone contacting element 54 are located adjacent to one another on the peripheral structure (figure 14). At least one of the two ends of the first arched bone contacting element 54 is substantially aligned with at least one of the two ends of the second arched bone contacting element 54 (figure 14). The first arched bone contacting element 54 extends along the peripheral structure and the second arched bone contacting element extends along the peripheral structure (figure 14); and wherein the first arched bone contacting element 54 extends at an oblique angle with respect to the second arched bone contacting element in order to substantially align with a curved portion of the peripheral structure (figure 14). PNG media_image1.png 742 662 media_image1.png Greyscale Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-13 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-20 of U.S. Patent No. 12097123 B2. Although the claims at issue are not identical, they are not patentably distinct from each other because the difference between the application claims and the patent claims lies in the fact that the patent claims include more elements and are thus more specific. Thus the invention of the patent claims are in effect a “species” of the “generic” invention of the application claims. It has been held that the generic invention is “anticipated” by the “species”. See In re Goodman, 29 USPQ2d 2010 (Fed. Cir. 1993). Since the application claims are anticipated by the patent claims, they are not patentably distinct from the patent claims. Allowable Subject Matter Claims 1-9 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. Claims 14-20 are allowed. The following is an examiner’s statement of reasons for allowance: The closest prior art, Chataigner et al. (Pub. No. US 2013/0226300 A1) fails to disclose at least wherein at least one of the two ends of the first arched bone contacting element is attached to and integrally formed with the peripheral structure, as required by claim 1. The arched bone contacting element of Charaigner is separated formed. None of the prior art discloses nor suggests a pair of parallel arched bone contacting elements extending between intermediate portions of support beams within an interior of an implant. Afzal (Pub. No. US 2017/0258606 A1) discloses arched bone contacting elements, but fails to disclose that they extend parallel to one another and between two support beams that are located in an interior of an implant. Any comments considered necessary by applicant must be submitted no later than the payment of the issue fee and, to avoid processing delays, should preferably accompany the issue fee. Such submissions should be clearly labeled “Comments on Statement of Reasons for Allowance.” Examiner’s Comment Several attempts were made to contact Applicant’s representative via telephone to discuss an Examiner’s Amendment to place the application in condition for allowance, but Examiner was unable to make contact with Applicant’s representative. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. See attached PTO form 892. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Lynnsy Summitt whose telephone number is (571)270-78567856. The examiner can normally be reached on Monday through Thursday from 8am until 5pm. If attempts to reach the examiner by telephone are unsuccessful, please contact the examiner’s supervisor, Eduardo Robert, at (571) 272-4719. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LYNNSY M SUMMITT/Primary Examiner, Art Unit 3773
Read full office action

Prosecution Timeline

Sep 23, 2024
Application Filed
Oct 02, 2026
Non-Final Rejection mailed — §102, §112, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12778759
Multi-Member Bone Structure Prostheses
4y 0m to grant Granted Nov 03, 2026
Patent 12778760
Systems, Apparatus and Methods for Stabilizing Sacroiliac Joints
2y 7m to grant Granted Nov 03, 2026
Patent 12751784
RETRACTOR SYSTEMS, DEVICES, AND METHODS FOR USE
3y 7m to grant Granted Oct 06, 2026
Patent 12751745
ROD REDUCING APPARATUS AND ASSOCIATED METHODS
2y 8m to grant Granted Oct 06, 2026
Patent 12746038
HOLE TRANSPORTER
3y 0m to grant Granted Sep 29, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
68%
Grant Probability
99%
With Interview (+43.4%)
Low
PTA Risk
Based on 697 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month